How do GLP-1 drugs work for weight loss?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame themselves for it.
GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.
Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
Some GLP-1s Achieve More Weight Loss Than Others: Study
We found that, of the 12 GLP-1 (drugs) identified by our search, the greatest mean body weight reduction was reported in randomized controlled trials of retatrutide, tirzepatid
GLP-1s cut surgery complication risk in some patients: Study
Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study. The study showed diabetic patients taking GLP-1 drugs,
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.
Health Matters: GLP-1 drugs work for weight loss, study finds
McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.
NJBIZ2d
GLP-1 users spend less at the supermarket, Cornell study finds
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...
FoodNavigator1d
Which GLP-1 drugs are on the market?
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
GlobalData on MSN2d
GLP-1 drugs reduce US grocery spending by 6%, study claims
GLP-1 drugs, such as Wegovy and Ozempic, are gaining popularity in the US and Europe for their appetite-suppressing ...
FierceBiotech2d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Flow Space on MSN6d
Doctors Are Using GLP-1 Drugs Off-Label to Treat More and More Conditions. Should You Consider It?
From addiction and heart disease to liver disease and sleep apnea, it seems like there's nothing that these new weight-loss ...
The Bulwark2d
Ozempic and Your Community
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced Alcohol Cravings
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
FiercePharma1d
Wegovy and Zepbound tipped to fuel $20B boom in heart failure market
GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...
Becker's Hospital Review13d
The GLP-1 dilemma persists into 2025
MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.